Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Mild cognitive impairment: an overview.

Petersen RC, Negash S.

CNS Spectr. 2008 Jan;13(1):45-53. Review.

PMID:
18204414
2.

Mild cognitive impairment as a diagnostic entity.

Petersen RC.

J Intern Med. 2004 Sep;256(3):183-94. Review.

3.

MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.

Meyer JS, Huang J, Chowdhury MH.

J Neurol Sci. 2007 Jun 15;257(1-2):97-104. Epub 2007 Feb 21.

PMID:
17316690
4.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Review.

PMID:
24913723
5.

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR Jr, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ; Alzheimer's Disease Cooperative Study.

Arch Neurol. 2004 Jan;61(1):59-66.

PMID:
14732621
6.

Mild cognitive impairment: current research and clinical implications.

Petersen RC.

Semin Neurol. 2007 Feb;27(1):22-31. Review.

PMID:
17226738
7.

Mild cognitive impairment: directions for future research.

Luis CA, Loewenstein DA, Acevedo A, Barker WW, Duara R.

Neurology. 2003 Aug 26;61(4):438-44. Review.

PMID:
12939414
8.

Mild cognitive impairment and dementia.

Albert MS, Blacker D.

Annu Rev Clin Psychol. 2006;2:379-88. Review.

PMID:
17716075
9.

Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Levey A, Lah J, Goldstein F, Steenland K, Bliwise D.

Clin Ther. 2006 Jul;28(7):991-1001. Review.

PMID:
16990077
10.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Review. French.

PMID:
22579080
11.

Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.

Ruan Q, D'Onofrio G, Sancarlo D, Bao Z, Greco A, Yu Z.

BMC Geriatr. 2016 May 16;16:104. doi: 10.1186/s12877-016-0281-7. Review.

12.

Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.

Morris JC.

Arch Neurol. 2012 Jun;69(6):700-8. doi: 10.1001/archneurol.2011.3152.

13.

VITA: subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years.

Jungwirth S, Weissgram S, Zehetmayer S, Tragl KH, Fischer P.

Int J Geriatr Psychiatry. 2005 May;20(5):452-8.

PMID:
15852463
14.

Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S.

Cochrane Database Syst Rev. 2015 Mar 5;(3):CD010783. doi: 10.1002/14651858.CD010783.pub2. Review.

PMID:
25740785
15.

Early diagnosis of Alzheimer's disease: is MCI too late?

Petersen RC.

Curr Alzheimer Res. 2009 Aug;6(4):324-30. Review.

16.

Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia.

Saxton J, Snitz BE, Lopez OL, Ives DG, Dunn LO, Fitzpatrick A, Carlson MC, Dekosky ST; GEM Study Investigators.

J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):737-43. doi: 10.1136/jnnp.2008.160705. Epub 2009 Mar 11.

17.

Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment.

Jak AJ, Bangen KJ, Wierenga CE, Delano-Wood L, Corey-Bloom J, Bondi MW.

Int Rev Neurobiol. 2009;84:81-103. doi: 10.1016/S0074-7742(09)00405-X. Review.

18.

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC.

Ann Neurol. 2011 Jan;69(1):181-92. doi: 10.1002/ana.22248.

19.

Diagnostic transitions in mild cognitive impairment subtypes.

Forlenza OV, Diniz BS, Nunes PV, Memória CM, Yassuda MS, Gattaz WF.

Int Psychogeriatr. 2009 Dec;21(6):1088-95. doi: 10.1017/S1041610209990792. Epub 2009 Aug 20.

PMID:
19691909
20.

Is the clock drawing test appropriate for screening for mild cognitive impairment?--Results of the German study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe).

Ehreke L, Luppa M, Luck T, Wiese B, Weyerer S, Eifflaender-Gorfer S, Weeg D, Olbrich J, van den Bussche H, Bachmann C, Eisele M, Maier W, Jessen F, Wagner M, Fuchs A, Pentzek M, Angermeyer MC, König HH, Riedel-Heller SG; AgeCoDe group.

Dement Geriatr Cogn Disord. 2009;28(4):365-72. doi: 10.1159/000253484. Epub 2009 Oct 30.

PMID:
19887799

Supplemental Content

Support Center